ArticleTheranostics

Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum.

Maximilian Klingler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.